Parkinson’s Disease
-
Inside a Pred’s Coach’s Deep Brain Stimulation Surgery
When the Nashville Predators take the ice—it’s all about strength, precision and teamwork. But when a beloved former coach with the Preds started feeling the harsh symptoms of Parkinson’s Disease—he turned to a team here at Vanderbilt. Coach Brent Peterson allowed VUCast’s Carole Bartoo and Mike Todd inside the operating… Read MoreJan 30, 2012
-
VUCast Newscast: Inside a Preds coach’s deep brain stimulation surgery
This Week on VUCast, Vanderbilt’s weekly newscast highlighting research, experts, students, sports and everything Vanderbilt: · Inside A Preds coach’s deep brain stimulation surgery · How nicotine could impact memory · Why a research lab wants Vandy undergrads [vucastblurb]… Read MoreJan 27, 2012
-
New schizophrenia drug candidates entering prep for first-in-human testing
The progression of new drug candidates for schizophrenia with partner Janssen Pharmaceutica is the latest evidence that a new collaborative model for drug discovery pioneered at Vanderbilt may help identify and develop innovative candidate drugs for treatment of major brain disorders. Read MoreDec 15, 2011
-
Parkinson’s deep brain target fired up
Neuronal activity in a deep brain region increases as Parkinson’s disease advances, a new study suggests. Read MoreOct 5, 2011
-
Researchers strive to refill drug discovery ‘pipeline’
Researchers at Vanderbilt University Medical Center have made substantial progress in developing potential new treatments for Parkinson’s disease, schizophrenia and fragile X syndrome, the most common genetic form of autism. Read MoreOct 3, 2011
-
Drug-like molecules aimed at improving treatment of Parkinson’s
Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects. Read MoreSep 30, 2011
-
Neuroscience drug discovery center opens at Vanderbilt
Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson's disease, schizophrenia and other disorders of the brain. Read MoreMar 11, 2011